Bio-Rad Laboratories (BIO) News Today $323.69 +3.03 (+0.94%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Natixis Advisors LLC Increases Stock Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)Natixis Advisors LLC boosted its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 24.3% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 41,323 shares of the medical research company's stock aftNovember 21 at 3:51 AM | marketbeat.comBio-Rad Laboratories Q3 Earnings TranscriptNovember 20 at 7:08 AM | marketbeat.comFrom crude lysate to purity with high-precision AAV capsid measurement with Bio-Rad's new ddPCR KitNovember 19 at 1:13 PM | msn.comBio-Rad Laboratories, Inc. (NYSE:BIO) Given Consensus Rating of "Moderate Buy" by AnalystsNovember 19 at 4:17 AM | americanbankingnews.comMawer Investment Management Ltd. Purchases 84,237 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)Mawer Investment Management Ltd. boosted its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 63.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 217,885 shares of the mediNovember 18 at 10:01 AM | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Stake Lowered by Sumitomo Mitsui Trust Group Inc.Sumitomo Mitsui Trust Group Inc. cut its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 18.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 37,964 shares of the medical research company's stockNovember 18 at 4:02 AM | marketbeat.comPrincipal Financial Group Inc. Increases Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)Principal Financial Group Inc. lifted its position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 95.6% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 44,341 shares of the medical research company'sNovember 16, 2024 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Short Interest UpdateBio-Rad Laboratories, Inc. (NYSE:BIO - Get Free Report) was the recipient of a significant decline in short interest in October. As of October 31st, there was short interest totalling 651,700 shares, a decline of 20.8% from the October 15th total of 823,100 shares. Based on an average daily volume of 291,900 shares, the short-interest ratio is presently 2.2 days. Currently, 3.4% of the company's stock are short sold.November 15, 2024 | marketbeat.comEntropy Technologies LP Makes New $1.41 Million Investment in Bio-Rad Laboratories, Inc. (NYSE:BIO)Entropy Technologies LP bought a new position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 4,200 shares of the medical research company'sNovember 14, 2024 | marketbeat.comEntropy Technologies LP Takes $1.41 Million Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)Entropy Technologies LP purchased a new stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) during the third quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 4,200 shares of the medical research company's stock, valued at approximatNovember 14, 2024 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Given Consensus Recommendation of "Moderate Buy" by AnalystsBio-Rad Laboratories, Inc. (NYSE:BIO - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the five brokerages that are covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a hold rating and three have given a buy rating to the company. The aveNovember 14, 2024 | marketbeat.comDNA Sequencing Market to Grow by USD 17.34 Billion (2024-2028), Driven by Rising NGS Adoption, AI-Powered Report Explores Market Evolution - TechnavioNovember 13, 2024 | finance.yahoo.comWhat Makes Bio-Rad Laboratories (BIO) an Attractive Opportunity?November 13, 2024 | finance.yahoo.comICICI Prudential Asset Management Co Ltd Has $9.47 Million Stock Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)ICICI Prudential Asset Management Co Ltd lifted its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 108.0% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 28,316 shares of the medical researNovember 13, 2024 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Bought by Amalgamated BankAmalgamated Bank grew its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 119.7% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 9,033 shares of the medical research company's stock after purchasing anNovember 11, 2024 | marketbeat.comRovin Capital UT ADV Invests $669,000 in Bio-Rad Laboratories, Inc. (NYSE:BIO)Rovin Capital UT ADV bought a new stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 1,999 shares of the medical research company's stock, vaNovember 9, 2024 | marketbeat.comKornitzer Capital Management Inc. KS Acquires 3,564 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)Kornitzer Capital Management Inc. KS grew its holdings in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 10.2% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 38,517 shares of the medical research company's stockNovember 7, 2024 | marketbeat.comHarbor Capital Advisors Inc. Purchases 3,840 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)Harbor Capital Advisors Inc. boosted its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 104.8% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 7,503 shares of the medical research company's stoNovember 5, 2024 | marketbeat.comVeritas Asset Management LLP Cuts Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)Veritas Asset Management LLP reduced its position in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 3.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,086,479 shares of the medical researchNovember 3, 2024 | marketbeat.comStockNews.com Upgrades Bio-Rad Laboratories (NYSE:BIO) to "Buy"StockNews.com upgraded Bio-Rad Laboratories from a "hold" rating to a "buy" rating in a research report on Friday.November 1, 2024 | marketbeat.comBio-Rad Laboratories (NYSE:BIO) Sets New 52-Week High on Analyst UpgradeBio-Rad Laboratories (NYSE:BIO) Sets New 1-Year High on Analyst UpgradeNovember 1, 2024 | marketbeat.comDekaBank Deutsche Girozentrale Has $4.03 Million Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)DekaBank Deutsche Girozentrale decreased its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 21.7% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,211 shares of the medNovember 1, 2024 | marketbeat.comBio-Rad Reports Third-Quarter 2024 Financial ResultsOctober 31, 2024 | finance.yahoo.comBio-Rad price target raised to $450 from $400 at CitiOctober 31, 2024 | markets.businessinsider.comRBC Capital Sticks to Their Buy Rating for Bio-Rad Laboratories (BIO)October 31, 2024 | markets.businessinsider.comBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Bought by Louisiana State Employees Retirement SystemLouisiana State Employees Retirement System grew its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 341.7% in the third quarter, according to its most recent filing with the SEC. The fund owned 5,300 shares of the medical research company's stock after acquiring an additiOctober 31, 2024 | marketbeat.comBio-Rad Laboratories beats quarterly profit estimates on strong sales in diagnostics unitOctober 30, 2024 | reuters.comBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Assenagon Asset Management S.A.Assenagon Asset Management S.A. reduced its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 22.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 41,960 shares of the medOctober 27, 2024 | marketbeat.comBio-Rad Laboratories (BIO) Scheduled to Post Earnings on WednesdayBio-Rad Laboratories (NYSE:BIO) will be releasing earnings after the market closes on Wednesday, October 30, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=635449)October 23, 2024 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Allspring Global Investments Holdings LLCAllspring Global Investments Holdings LLC decreased its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 4.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 148,722 shares of theOctober 23, 2024 | marketbeat.comBio-Rad Laboratories (NYSE:BIO) Shares Gap Up - Still a Buy?Bio-Rad Laboratories (NYSE:BIO) Shares Gap Up - Here's WhyOctober 17, 2024 | marketbeat.comBio-Rad Laboratories (NYSE:BIO) Stock Price Down 2.8% - Here's What HappenedBio-Rad Laboratories (NYSE:BIO) Shares Down 2.8% - What's Next?October 16, 2024 | marketbeat.comBio-Rad Laboratories, Inc. Forecasted to Post Q3 2024 Earnings of $1.28 Per Share (NYSE:BIO)Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) - Zacks Research issued their Q3 2024 earnings per share (EPS) estimates for Bio-Rad Laboratories in a research note issued to investors on Monday, October 14th. Zacks Research analyst R. Department expects that the medical research company willOctober 16, 2024 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Danaher (DHR) and Thermo Fisher (TMO)October 16, 2024 | markets.businessinsider.comBio-Rad Laboratories, Inc. (NYSE:BIO) Forecasted to Earn Q4 2024 Earnings of $2.77 Per ShareBio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) - Analysts at Zacks Research dropped their Q4 2024 EPS estimates for shares of Bio-Rad Laboratories in a research report issued on Monday, October 14th. Zacks Research analyst R. Department now forecasts that the medical research company will eaOctober 15, 2024 | marketbeat.comBio-Rad to Report Third Quarter 2024 Financial Results on Wednesday, October 30, 2024October 14, 2024 | businesswire.comSanctuary Advisors LLC Buys Shares of 2,663 Bio-Rad Laboratories, Inc. (NYSE:BIO)Sanctuary Advisors LLC bought a new stake in Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 2,663 shares of the medical research company's stock, valued at approximately $October 14, 2024 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Sees Significant Decrease in Short InterestBio-Rad Laboratories, Inc. (NYSE:BIO - Get Free Report) was the recipient of a significant drop in short interest in September. As of September 30th, there was short interest totalling 851,300 shares, a drop of 36.9% from the September 15th total of 1,350,000 shares. Based on an average daily volume of 309,900 shares, the days-to-cover ratio is presently 2.7 days. Approximately 4.5% of the company's stock are sold short.October 12, 2024 | marketbeat.comBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Truist Financial CorpTruist Financial Corp trimmed its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 16.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 8,931 shares of the medical research company's stock after selOctober 11, 2024 | marketbeat.comRK Asset Management LLC Makes New $5.20 Million Investment in Bio-Rad Laboratories, Inc. (NYSE:BIO)RK Asset Management LLC bought a new stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 15,537 shares of the medical research company's stock, valued at approOctober 7, 2024 | marketbeat.comParagon Capital Management Inc. Purchases Shares of 4,793 Bio-Rad Laboratories, Inc. (NYSE:BIO)Paragon Capital Management Inc. acquired a new position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 4,793 shares of the medical researOctober 3, 2024 | marketbeat.comCitigroup Upgrades Bio-Rad Laboratories (BIO.B)October 2, 2024 | msn.comCitigroup Upgrades Bio-Rad Laboratories (BIO)October 2, 2024 | msn.comAQR Capital Management LLC Has $13.09 Million Stock Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)AQR Capital Management LLC lifted its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 4.0% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 47,954 shares of the medical research company's stock aOctober 2, 2024 | marketbeat.comAssessment of Western Blotting Markets Through 2030, Featuring Strategic Analysis of Advansta, Bio-Rad Labs, LI-COR, Merck, PerkinElmer & MoreOctober 1, 2024 | finance.yahoo.comExpert Ratings For Bio-Rad LaboratoriesOctober 1, 2024 | benzinga.comWilliam B. Walkup & Associates Inc. Makes New $519,000 Investment in Bio-Rad Laboratories, Inc. (NYSE:BIO)William B. Walkup & Associates Inc. bought a new position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 1,902 shares of the medical researchSeptember 30, 2024 | marketbeat.comScientech Research LLC Invests $1.19 Million in Bio-Rad Laboratories, Inc. (NYSE:BIO)Scientech Research LLC acquired a new position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 4,343 shares of the medical research company's stock, vSeptember 28, 2024 | marketbeat.comFood Diagnostics Market Overview, Growth Drivers, Key Segments, Latest Trends, Regional Insight, Recent Developments, and Top CompaniesSeptember 27, 2024 | theglobeandmail.comSelect Equity Group L.P. Purchases 134,856 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)Select Equity Group L.P. increased its position in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Free Report) by 26.2% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 649,522 shares of the medical research company's stoSeptember 27, 2024 | marketbeat.com Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter. Email Address 📉 Warning: Market Crash Predicted - Secure Your Savings (Ad)The last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%. Take these 4 steps to protect your retirement here >>> BIO Media Mentions By Week BIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIO News Sentiment▼1.020.45▲Average Medical News Sentiment BIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIO Articles This Week▼106▲BIO Articles Average Week Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Mettler-Toledo International News Illumina News Waters News Bio-Techne News Charles River Laboratories International News Bruker News Pacific Biosciences of California News Harvard Bioscience News Thermo Fisher Scientific News Agilent Technologies News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BIO) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Rad Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BIO Stock Alerts